Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-Centre Study of Tamoxifen Dose Escalation Study in Breast Cancer Patients With CYP2D6 Polymorphisms

NCT01075802 is registered in ClinicalTrials.gov with Western Sydney Local Health District as lead sponsor.

NCT NCT01075802
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01075802 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-Centre Study of Tamoxifen Dose Escalation Study in Breast Cancer Patients With CYP2D6 Polymorphisms
Lead sponsor
Western Sydney Local Health District
Phase
Not applicable
Overall status
Completed
Start date
March 31, 2010
Completion date
December 31, 2012
Enrollment
121 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, cyp2d6 polymorphism